Dr. Jerzy Szaflarski talks about the FDA's approval of the first cannabis-derived pharmaceutical for the treatment of epilepsy and Lennox-Gastaut syndrome in particular. For more, read the full article, "The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We Out of the Haze?" by Dr. Szaflarski in JAMA Neurology: https://jamanetwork.com/journals/jamaneurology/article-abstract/2714720.